Compare RZLT & WHF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RZLT | WHF |
|---|---|---|
| Founded | 2010 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 187.3M | 162.2M |
| IPO Year | N/A | 2012 |
| Metric | RZLT | WHF |
|---|---|---|
| Price | $2.02 | $7.26 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 6 | 2 |
| Target Price | ★ $12.33 | $7.75 |
| AVG Volume (30 Days) | ★ 12.2M | 194.9K |
| Earning Date | 11-06-2025 | 11-10-2025 |
| Dividend Yield | N/A | ★ 24.69% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.42 |
| Revenue | N/A | ★ $76,339,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $17.05 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.07 | $6.39 |
| 52 Week High | $11.46 | $11.31 |
| Indicator | RZLT | WHF |
|---|---|---|
| Relative Strength Index (RSI) | 25.06 | 45.79 |
| Support Level | $1.07 | $7.13 |
| Resistance Level | $1.85 | $7.84 |
| Average True Range (ATR) | 0.64 | 0.19 |
| MACD | -0.94 | -0.03 |
| Stochastic Oscillator | 9.26 | 15.45 |
Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causing excessive insulin production and resulting hypoglycemia. Rezolute's pipeline includes drug candidates designed to improve patient outcomes while reducing treatment burdens. The company engages in research, development, and clinical trials to advance its therapies and collaborates with medical communities and patient groups to support its objectives. Revenue and value creation depend largely on successful product development and regulatory approvals.
WhiteHorse Finance Inc is a non-diversified, closed-end management investment company. It makes debt investments in privately held; small-cap companies located in United States. Its investment objective is to generate risk-adjusted returns by originating and investing in senior secured loans, including first lien and second lien facilities, to performing lower middle market companies across a range of industries.